Increased serum HMGB1 levels in patients with Henoch-Schönlein purpura

Experimental Dermatology

Volumn 23, Issue 6, 2014, Pages 419-423

  Chen, Tao ^a,b   Guo, Zai pei ^a   Wang, Wen ju ^b   Qin, Sha ^a   Cao, Na ^a   Li, Meng meng ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU SECOND PEOPLE S HOSPITAL   (China)

Author keywords

Cytokine; Endothelial cells; Henoch Sch nlein purpura; High mobility group box 1

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA INHIBITOR; INTERLEUKIN 6; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HMGB1 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTOCLASTIC VASCULITIS; MALE; MICROVASCULAR ENDOTHELIAL CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; VASCULITIS; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PURPURA, SCHOENLEIN-HENOCH; URTICARIA; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-6; MALE; NF-KAPPA B; PURPURA, SCHOENLEIN-HENOCH; TUMOR NECROSIS FACTOR-ALPHA; URTICARIA; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS; YOUNG ADULT;

EID: 84901496978     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12422     Document Type: Article

References (30)

1. Linskey K R, Kroshinsky D, Mihm M C Jr et al. J Am Acad Dermatol 2012: 66: 813-822.
2. Chen T, Guo Z P, Jiao X Y et al. Arch Dermatol Res 2011: 303: 715-725.
3. Chen T, Guo Z P, Li M M et al. Clin Exp Immunol 2011: 166: 64-71.
4. Chen T, Jia R Z, Guo Z P et al. Arch Dermatol Res 2013: 305: 173-177.
5. Lotze M T, Tracey K J. Nat Rev Immunol 2005: 5: 331-342.
6. Petrof G, Abdul-Wahab A, Proudfoot L et al. Exp Dermatol 2013: 22: 433-435.
7. Rendon-Mitchell B, Ochani M, Li J et al. J Immunol 2003: 170: 3890-3897.
8. Luan Z G, Zhang H, Yang P T et al. Immunobiology 2010: 215: 956-962.
9. Abdulahad D A, Westra J, Limburg P C et al. Autoimmun Rev 2010: 9: 661-665.
10. Goldstein R S, Bruchfeld A, Yang L et al. Mol Med 2007: 13: 210-215.
11. Chen T, Guo Z P, Li L et al. Arch Dermatol Res 2013: 305: 263-267.
12. Sato F, Maruyama S, Hayashi H et al. Nephron Clin Pract 2008: 108: c194-c201.
13. Mills J A, Michel B A, Bloch D A et al. Arthritis Rheum 1990: 33: 1114-1121.
14. Chen T, Guo Z P, Zhang Y H et al. Rheumatol Int 2011: 31: 321-326.
15. Mollica L, De Marchis F, Spitaleri A et al. Chem Biol 2007: 14: 431-441.
16. Yang Y H, Lai H J, Huang C M et al. Ann Rheum Dis 2004: 63: 1511-1513.
17. Scholzen T E, Sunderkötter C, Kalden D H et al. Endocrinology 2003: 144: 360-370.
18. Mullins G E, Sunden-Cullberg J, Johansson A S et al. Scand J Immunol 2004: 60: 566-573.
19. Kim S W, Jin Y, Shin J H et al. Neurobiol Dis 2012: 46: 147-156.
20. Gong G, Yuan L B, Hu L et al. Acta Pharmacol Sin 2012: 33: 11-18.
21. Fiuza C, Bustin M, Talwar S et al. Blood 2003: 101: 2652-2660.
22. Ha T S. Pediatr Nephrol 2005: 20: 149-153.
23. Lin C Y, Yang Y H, Lee C C et al. J Microbiol Immunol Infect 2006: 39: 476-482.
24. Kobayashi S, Nagino M, Komatsu S et al. Biochem Biophys Res Commun 2003: 308: 306-312.
25. Tak P P, Firestein G S. J Clin Invest 2001: 107: 7-11.
26. Karin M, Delhase M. Semin Immunol 2000: 12: 85-98.
27. Tanaka N, Yonekura H, Yamagishi S et al. J Biol Chem 2000: 275: 25781-25790.
28. Yu M, Wang H, Ding A et al. Shock 2006: 26: 174-179.
29. Yang H, Hreggvidsdottir H S, Palmblad K et al. Proc Natl Acad Sci U S A 2010: 107: 11942-11947.
30. Li Y, Xiang M, Yuan Y et al. Am J Physiol Regul Integr Comp Physiol 2009: 297: R1670-R1680.